| 000 | 01555 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250517193125.0 | ||
| 264 | 0 | _c20190408 | |
| 008 | 201904s 0 0 eng d | ||
| 022 | _a1520-6017 | ||
| 024 | 7 |
_a10.1016/j.xphs.2017.12.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPurohit, Hitesh S | |
| 245 | 0 | 0 |
_aInvestigating the Impact of Drug Crystallinity in Amorphous Tacrolimus Capsules on Pharmacokinetics and Bioequivalence Using Discriminatory In Vitro Dissolution Testing and Physiologically Based Pharmacokinetic Modeling and Simulation. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _c05 2018 |
||
| 300 |
_a1330-1341 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aCapsules |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aCrystallization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 | _aPowder Diffraction |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTacrolimus _xadministration & dosage |
| 650 | 0 | 4 | _aTherapeutic Equivalency |
| 650 | 0 | 4 | _aX-Ray Diffraction |
| 700 | 1 | _aTrasi, Niraj S | |
| 700 | 1 | _aSun, Dajun D | |
| 700 | 1 | _aChow, Edwin C Y | |
| 700 | 1 | _aWen, Hong | |
| 700 | 1 | _aZhang, Xinyuan | |
| 700 | 1 | _aGao, Yi | |
| 700 | 1 | _aTaylor, Lynne S | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 107 _gno. 5 _gp. 1330-1341 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.xphs.2017.12.024 _zAvailable from publisher's website |
| 999 |
_c27936778 _d27936778 |
||